Barrington Research Maintains Outperform Rating on IMAX (IMAX)

February 25, 2013 3:21 PM

Barrington Research today reiterated a Buy rating on IMAX Corporation (NYSE: IMAX) and trimmed its price target to $36 from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found